Protective Effects of Therapeutic Neutrophil Depletion and Myeloperoxidase Inhibition on Left Ventricular Function and Remodeling in Myocardial Infarction
Myocardial infarction (MI) is a leading cause of morbidity and mortality worldwide. Improved survival has led to an increasing incidence of ischemic cardiomyopathy, making it a major reason for hospitalization in the western world. The inflammatory response in the ischemic myocardium determines the...
Main Authors: | Henning Guthoff, Alexander Hof, Anna Klinke, Martina Maaß, Jürgen Konradi, Dennis Mehrkens, Simon Geißen, Felix S. Nettersheim, Simon Braumann, Erik Michaelsson, Richard J. Nies, Samuel Lee, Marie-Christin Redzinski, Vera B. M. Peters, Harshal N. Nemade, Philipp von Stein, Holger Winkels, Volker Rudolph, Stephan Baldus, Matti Adam, Martin Mollenhauer |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Antioxidants |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3921/12/1/33 |
Similar Items
-
Myeloperoxidase PET Imaging Tracks Intracellular and Extracellular Treatment Changes in Experimental Myocardial Infarction
by: Matthias W. G. Zeller, et al.
Published: (2023-03-01) -
The Enzymatic and Non-Enzymatic Function of Myeloperoxidase (MPO) in Inflammatory Communication
by: Yulia Kargapolova, et al.
Published: (2021-04-01) -
Myeloperoxidase (MPO) – possible diagnosis biomarker and risk stratification in myocardial inotropism deficit induced by chronic ischemic heart disease
by: Gabi Valeriu Dinca, et al.
Published: (2022-09-01) -
Genetic and clinical study of myeloperoxidase's association with coronary artery disease
by: Lina N. Adam, et al.
Published: (2024-02-01) -
The Role of Myeloperoxidase in Clozapine-Induced Inflammation: A Mechanistic Update for Idiosyncratic Drug-Induced Agranulocytosis
by: Samantha Christine Sernoskie, et al.
Published: (2023-01-01)